Drug Shortage Report for MIDAZOLAM INJECTION
Report ID | 93924 |
Drug Identification Number | 02242904 |
Brand name | MIDAZOLAM INJECTION |
Common or Proper name | Midazolam Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 2mL |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-09-13 |
Estimated end date | 2020-01-31 |
Actual end date | 2019-12-04 |
Shortage status | Resolved |
Updated date | 2020-01-16 |
Company comments | Available December 4, 2019 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-09-13 | English | Compare |
v2 | 2019-09-13 | French | Compare |
v3 | 2019-09-14 | English | Compare |
v4 | 2020-01-16 | English | Compare |
v5 | 2020-01-16 | English | Compare |
v6 | 2020-01-16 | French | Compare |
Showing 1 to 6 of 6